Literature DB >> 10409139

A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo.

S F Previs1, G W Cline, G I Shulman.   

Abstract

There are conflicting reports concerning the reliability of mass isotopomer distribution analysis (MIDA) for estimating the contribution of gluconeogenesis to total glucose production (f) during [(13)C]glycerol infusion. We have evaluated substrate-induced effects on rate of appearance (R(a)) of glycerol and glucose and f during [2-(13)C]glycerol infusion in vivo. Five groups of mice were fasted for 30 h and then infused with [2-(13)C]glycerol at variable rates and variable (13)C enrichments (group I: 20 micromol. kg(-1). min(-1), 99% (13)C; group II: 60 micromol. kg(-1). min(-1), 60% (13)C; group III: 60 micromol. kg(-1). min(-1), 99% (13)C; group IV: 120 micromol. kg(-1). min(-1), 40% (13)C; or group V: 120 micromol. kg(-1). min(-1), 99% (13)C). The total glycerol R(a) increased from approximately 104 to approximately 157 and to approximately 210 micromol. kg(-1). min(-1) as the infusion of [2-(13)C]glycerol increased from 20 to 60 and to 120 micromol. kg(- 1). min(-1), respectively. As the amount of 99% enriched [2-(13)C]glycerol increased from 20 to 60 and to 120 micromol. kg(-1). min(-1) (groups I, III, and V, respectively), plasma glycerol enrichment increased from approximately 21 to approximately 42 and to approximately 57% and the calculated f increased from approximately 27 to approximately 56 and to approximately 87%, respectively. Similar plasma glycerol enrichments were observed in groups I, II, and IV (i. e., approximately 21-24%), yet f increased from approximately 27 to approximately 57 and to approximately 86% in groups II and IV, respectively. Estimates of absolute gluconeogenesis increased from approximately 14 to approximately 33 and approximately 86 micromol. kg(-1). min(-1) as the infusion of [2-(13)C]glycerol increased from 20 to 60 and 120 micromol. kg(-1). min(-1). Plausible estimates of f were obtained only under conditions that increased total glycerol R(a) approximately 2-fold (P < 0.001) and increased glucose R(a) approximately 1.5-fold (P < 0.01) above basal. We conclude that in 30-h fasted mice, 1) estimates of f by MIDA with low infusion rates of [2-(13)C]glycerol yield erroneous results and 2) reasonable estimates of f are obtained at glycerol infusion rates that perturb glycerol and glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409139     DOI: 10.1152/ajpendo.1999.277.1.E154

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

2.  Gluconeogenesis during endurance exercise in cyclists habituated to a long-term low carbohydrate high-fat diet.

Authors:  Christopher C Webster; Timothy D Noakes; Shaji K Chacko; Jeroen Swart; Tertius A Kohn; James A H Smith
Journal:  J Physiol       Date:  2016-06-08       Impact factor: 5.182

3.  Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.

Authors:  Daniel F Vatner; Dirk Weismann; Sara A Beddow; Naoki Kumashiro; Derek M Erion; Xiao-Hui Liao; Gary J Grover; Paul Webb; Kevin J Phillips; Roy E Weiss; Jonathan S Bogan; John Baxter; Gerald I Shulman; Varman T Samuel
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

4.  Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance.

Authors:  João Paulo Camporez; Kun Lyu; Emily L Goldberg; Dongyan Zhang; Gary W Cline; Michael J Jurczak; Vishwa Deep Dixit; Kitt Falk Petersen; Gerald I Shulman
Journal:  J Physiol       Date:  2019-07-04       Impact factor: 5.182

5.  The Role of Leptin in Maintaining Plasma Glucose During Starvation.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  Postdoc J       Date:  2018-03

Review 6.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

7.  The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species.

Authors:  David G McLaren; Timothy He; Sheng-Ping Wang; Vivienne Mendoza; Raymond Rosa; Karen Gagen; Gowri Bhat; Kithsiri Herath; Paul L Miller; Sloan Stribling; Andrew Taggart; Jason Imbriglio; Jinqi Liu; Dunlu Chen; Shirly Pinto; James M Balkovec; Robert J Devita; Donald J Marsh; Jose M Castro-Perez; Alison Strack; Douglas G Johns; Stephen F Previs; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

8.  Optimization of 13C isotopic tracers for metabolic flux analysis in mammalian cells.

Authors:  Jason L Walther; Christian M Metallo; Jie Zhang; Gregory Stephanopoulos
Journal:  Metab Eng       Date:  2011-12-19       Impact factor: 9.783

9.  Mechanism by which metformin reduces glucose production in type 2 diabetes.

Authors:  R S Hundal; M Krssak; S Dufour; D Laurent; V Lebon; V Chandramouli; S E Inzucchi; W C Schumann; K F Petersen; B R Landau; G I Shulman
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

10.  Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Authors:  Varman T Samuel; Sara A Beddow; Takanori Iwasaki; Xian-Man Zhang; Xin Chu; Christopher D Still; Glenn S Gerhard; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.